PTCT logo

PTC Therapeutics (PTCT) Free cash flow

annual FCF:

-$181.94M+$97.10M(+34.80%)
December 31, 2024

Summary

  • As of today (May 21, 2025), PTCT annual free cash flow is -$181.94 million, with the most recent change of +$97.10 million (+34.80%) on December 31, 2024.
  • During the last 3 years, PTCT annual FCF has risen by +$154.73 million (+45.96%).
  • PTCT annual FCF is now -769.19% below its all-time high of -$20.93 million, reached on December 31, 2011.

Performance

PTCT Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTCTcash flow metrics

quarterly FCF:

$867.57M+$904.07M(+2476.84%)
March 1, 2025

Summary

  • As of today (May 21, 2025), PTCT quarterly free cash flow is $867.57 million, with the most recent change of +$904.07 million (+2476.84%) on March 1, 2025.
  • Over the past year, PTCT quarterly FCF has increased by +$861.16 million (+13434.65%).
  • PTCT quarterly FCF is now at all-time high.

Performance

PTCT quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTCTcash flow metrics

TTM FCF:

$679.22M+$861.16M(+473.33%)
March 1, 2025

Summary

  • As of today (May 21, 2025), PTCT TTM free cash flow is $679.22 million, with the most recent change of +$861.16 million (+473.33%) on March 1, 2025.
  • Over the past year, PTCT TTM FCF has increased by +$878.69 million (+440.52%).
  • PTCT TTM FCF is now at all-time high.

Performance

PTCT TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPTCTcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

PTCT Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+34.8%+10000.0%+440.5%
3 y3 years+46.0%+585.1%+271.7%
5 y5 years-26.3%+976.2%+443.4%

PTCT Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+64.3%at high+549.6%at high+233.4%
5 y5-year-26.3%+64.3%at high+549.6%at high+233.4%
alltimeall time-769.2%+64.3%at high+549.6%at high+233.4%

PTCT Free cash flow History

DateAnnualQuarterlyTTM
Mar 2025
-
$867.57M(-2476.8%)
$679.22M(-473.3%)
Dec 2024
-$181.94M(-34.8%)
-$36.50M(-58.4%)
-$181.94M(-33.6%)
Sep 2024
-
-$87.77M(+37.0%)
-$274.19M(+19.1%)
Jun 2024
-
-$64.08M(-1099.7%)
-$230.14M(+15.4%)
Mar 2024
-
$6.41M(-105.0%)
-$199.47M(-28.5%)
Dec 2023
-$279.04M(-45.2%)
-$128.75M(+194.5%)
-$279.04M(-18.7%)
Sep 2023
-
-$43.73M(+30.9%)
-$343.25M(-5.6%)
Jun 2023
-
-$33.40M(-54.3%)
-$363.59M(-9.9%)
Mar 2023
-
-$73.16M(-62.1%)
-$403.42M(-20.8%)
Dec 2022
-$509.11M(+51.2%)
-$192.96M(+201.2%)
-$509.11M(+24.5%)
Sep 2022
-
-$64.07M(-12.5%)
-$409.03M(-3.1%)
Jun 2022
-
-$73.23M(-59.1%)
-$421.96M(+6.7%)
Mar 2022
-
-$178.85M(+92.6%)
-$395.50M(+17.5%)
Dec 2021
-$336.66M(+34.6%)
-$92.88M(+20.6%)
-$336.66M(+2.9%)
Sep 2021
-
-$77.00M(+64.7%)
-$327.02M(+30.9%)
Jun 2021
-
-$46.77M(-61.0%)
-$249.86M(-7.8%)
Mar 2021
-
-$120.02M(+44.2%)
-$271.06M(+8.4%)
Dec 2020
-$250.05M(+73.6%)
-$83.23M(<-9900.0%)
-$250.05M(+29.5%)
Sep 2020
-
$155.00K(-100.2%)
-$193.10M(-12.7%)
Jun 2020
-
-$67.96M(-31.4%)
-$221.28M(+11.9%)
Mar 2020
-
-$99.01M(+276.6%)
-$197.81M(+37.3%)
Dec 2019
-$144.08M(+233.7%)
-$26.29M(-6.2%)
-$144.08M(+1.4%)
Sep 2019
-
-$28.02M(-37.0%)
-$142.07M(+22.6%)
Jun 2019
-
-$44.49M(-1.7%)
-$115.87M(+60.7%)
Mar 2019
-
-$45.27M(+86.5%)
-$72.09M(+67.0%)
Dec 2018
-$43.17M
-$24.28M(+1228.3%)
-$43.17M(<-9900.0%)
Sep 2018
-
-$1.83M(+159.3%)
$355.00K(-100.4%)
DateAnnualQuarterlyTTM
Jun 2018
-
-$705.00K(-95.7%)
-$91.23M(+17.6%)
Mar 2018
-
-$16.36M(-185.0%)
-$77.56M(-14.1%)
Dec 2017
-$90.33M(-14.3%)
$19.25M(-120.6%)
-$90.33M(-27.2%)
Sep 2017
-
-$93.41M(-820.4%)
-$124.13M(+125.5%)
Jun 2017
-
$12.97M(-144.5%)
-$55.06M(-40.6%)
Mar 2017
-
-$29.13M(+100.1%)
-$92.62M(-12.1%)
Dec 2016
-$105.34M(-17.1%)
-$14.55M(-40.2%)
-$105.34M(-13.7%)
Sep 2016
-
-$24.34M(-1.0%)
-$122.08M(-3.2%)
Jun 2016
-
-$24.59M(-41.2%)
-$126.08M(-4.2%)
Mar 2016
-
-$41.85M(+33.8%)
-$131.60M(+3.6%)
Dec 2015
-$127.06M(+105.1%)
-$31.29M(+10.4%)
-$127.06M(+18.4%)
Sep 2015
-
-$28.35M(-5.9%)
-$107.27M(+11.4%)
Jun 2015
-
-$30.11M(-19.3%)
-$96.28M(+12.4%)
Mar 2015
-
-$37.31M(+224.4%)
-$85.62M(+38.2%)
Dec 2014
-$61.94M(+29.7%)
-$11.50M(-33.7%)
-$61.94M(-5.1%)
Sep 2014
-
-$17.36M(-10.8%)
-$65.27M(+22.1%)
Jun 2014
-
-$19.46M(+42.8%)
-$53.47M(-0.1%)
Mar 2014
-
-$13.62M(-8.2%)
-$53.52M(+12.0%)
Dec 2013
-$47.77M(-0.7%)
-$14.84M(+167.1%)
-$47.77M(+8.6%)
Sep 2013
-
-$5.55M(-71.5%)
-$43.98M(-1.4%)
Jun 2013
-
-$19.51M(+148.0%)
-$44.62M(+13.7%)
Mar 2013
-
-$7.87M(-28.7%)
-$39.25M(-18.4%)
Dec 2012
-$48.12M(+129.9%)
-$11.04M(+78.1%)
-$48.12M(+29.8%)
Sep 2012
-
-$6.20M(-56.1%)
-$37.07M(+20.1%)
Jun 2012
-
-$14.14M(-15.5%)
-$30.87M(+84.5%)
Mar 2012
-
-$16.74M
-$16.74M
Dec 2011
-$20.93M
-
-

FAQ

  • What is PTC Therapeutics annual free cash flow?
  • What is the all time high annual FCF for PTC Therapeutics?
  • What is PTC Therapeutics annual FCF year-on-year change?
  • What is PTC Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for PTC Therapeutics?
  • What is PTC Therapeutics quarterly FCF year-on-year change?
  • What is PTC Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for PTC Therapeutics?
  • What is PTC Therapeutics TTM FCF year-on-year change?

What is PTC Therapeutics annual free cash flow?

The current annual FCF of PTCT is -$181.94M

What is the all time high annual FCF for PTC Therapeutics?

PTC Therapeutics all-time high annual free cash flow is -$20.93M

What is PTC Therapeutics annual FCF year-on-year change?

Over the past year, PTCT annual free cash flow has changed by +$97.10M (+34.80%)

What is PTC Therapeutics quarterly free cash flow?

The current quarterly FCF of PTCT is $867.57M

What is the all time high quarterly FCF for PTC Therapeutics?

PTC Therapeutics all-time high quarterly free cash flow is $867.57M

What is PTC Therapeutics quarterly FCF year-on-year change?

Over the past year, PTCT quarterly free cash flow has changed by +$861.16M (+13434.65%)

What is PTC Therapeutics TTM free cash flow?

The current TTM FCF of PTCT is $679.22M

What is the all time high TTM FCF for PTC Therapeutics?

PTC Therapeutics all-time high TTM free cash flow is $679.22M

What is PTC Therapeutics TTM FCF year-on-year change?

Over the past year, PTCT TTM free cash flow has changed by +$878.69M (+440.52%)
On this page